hg_10003.1

Basic information about the TSS

---

TSS ID: hg_10003.1 Species: human Chr: chr1		Start: 6235915 End: 6235943 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: BC028168 Distance: 0 GeneID: 23463 HGNC/MGI_ID: HGNC:5350 UniProt_ID:

Gene_name: isoprenylcysteine carboxyl methyltransferase Gene_symbol: ICMT Gene_synonyms: HSTE14 PCCMT PPMT Gene_source: HGNC:5350

TATA-Box annotation

---

Distance to TSS:	35
Nearest PromoterID:	NM_012405
Entrez ID:	23463
Nearest Unigene:	Hs.515688
Nearest Refseq:	NM_012405
Nearest Ensembl:	ENSG00000116237
Gene Name:	isoprenylcysteine carboxyl methyltransferase
Gene Alias:	HSTE14|MST098|MSTP098|PCCMT|PCMT|PPMT
Gene Description:	isoprenylcysteine carboxyl methyltransferase
Gene Type:	protein-coding
CpG%:	0.16
GC%:	0.791045
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ICMT p2@ICMT
Sample		p1@ICMT	p2@ICMT
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	33.51	24.55
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	38.44	22.46
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	33.18	21.03
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	26.20	25.78
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	31.27	22.72
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	24.03	14.54
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	44.67	27.67
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	37.54	22.28
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	31.63	27.78
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	30.72	19.71
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	29.91	18.19
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	32.93	23.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	14.51	9.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	11.73	6.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	15.15	7.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	13.83	7.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	13.32	4.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	16.87	6.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	11.73	3.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	11.73	6.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	12.96	8.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	12.08	7.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	13.70	5.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	15.53	8.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	12.64	5.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	12.98	6.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	13.74	4.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	10.61	10.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	10.98	6.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	12.49	7.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	12.98	9.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	12.50	6.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	10.76	4.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	8.41	4.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	14.02	5.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	16.86	8.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	11.45	6.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	11.89	8.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	13.51	7.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	12.24	6.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	13.41	9.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	8.78	5.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	15.18	9.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	17.83	7.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	15.06	8.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	16.75	8.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	17.27	12.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	14.31	7.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	16.04	12.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	15.37	8.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	21.11	9.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	18.90	12.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	23.78	13.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	23.53	8.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	10.07	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	8.27	3.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	28.85	11.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	26.34	14.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	13.52	7.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	27.50	10.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	25.24	14.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	7.96	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	12.91	3.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	23.72	12.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	23.43	12.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	25.84	12.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	29.26	11.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	22.05	8.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	13.25	7.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	30.32	14.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	31.49	16.82
Adipocyte - breast, donor1	11376-118A8	42.45	14.41
Adipocyte - breast, donor2	11327-117E4	29.84	13.96
Adipocyte - omental, donor1	11473-119C6	47.58	22.77
Adipocyte - omental, donor2	11474-119C7	33.64	12.71
Adipocyte - omental, donor3	11475-119C8	21.77	12.06
Adipocyte - perirenal, donor1	11476-119C9	45.94	10.21
Adipocyte - subcutaneous, donor1	11259-116F8	16.49	4.40
Adipocyte - subcutaneous, donor2	11336-117F4	25.74	9.94
Adipocyte - subcutaneous, donor3	11408-118E4	27.63	14.42
Adipocyte differentiation, day04, donor1	13019-139D4	29.53	15.45
Adipocyte differentiation, day04, donor2	13022-139D7	19.30	9.27
Adipocyte differentiation, day04, donor3	13025-139E1	23.14	13.66
Adipocyte differentiation, day04, donor4	13028-139E4	25.28	9.99
Adipocyte differentiation, day08, donor1	13020-139D5	24.45	12.63
Adipocyte differentiation, day08, donor2	13023-139D8	20.01	12.26
Adipocyte differentiation, day08, donor3	13026-139E2	18.13	5.87
Adipocyte differentiation, day08, donor4	13029-139E5	17.81	8.35
Adipocyte differentiation, day12, donor1	13021-139D6	13.72	14.56
Adipocyte differentiation, day12, donor2	13024-139D9	20.34	10.30
Adipocyte differentiation, day12, donor3	13027-139E3	18.33	8.18
Adipocyte differentiation, day12, donor4	13030-139E6	17.05	8.83
Alveolar Epithelial Cells, donor1	11510-119G7	41.99	24.31
Alveolar Epithelial Cells, donor2	11590-120G6	19.72	10.04
Alveolar Epithelial Cells, donor3	11671-122G6	15.57	3.59
Amniotic Epithelial Cells, donor1	11533-120A3	29.68	18.17
Amniotic Epithelial Cells, donor2	11613-122A2	20.08	5.02
Amniotic Epithelial Cells, donor3	11694-123A2	25.06	14.79
Anulus Pulposus Cell, donor1	11248-116E6	11.56	5.49
Anulus Pulposus Cell, donor2	11463-119B5	16.16	4.41
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	12.58	4.04
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	11.29	4.34
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	12.84	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	13.45	3.89
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	6.32	6.32
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	16.50	2.64
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	10.40	4.22
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	14.08	3.88
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	10.69	4.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	9.79	5.27
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	10.89	2.90
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	11.28	3.76
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	18.12	5.11
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	6.82	5.46
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	22.32	4.22
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	10.72	3.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	15.30	4.72
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	14.70	3.47
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	10.73	3.90
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	15.09	3.81
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	15.61	6.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	14.24	4.63
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	12.58
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	15.05	2.91
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	12.52	3.79
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	16.96	4.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	10.26	2.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	15.82	2.78
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	13.42	2.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	9.85	2.82
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	12.22	5.14
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	19.98	5.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	9.36	5.26
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	18.67	5.42
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	14.26	4.75
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	12.21	2.03
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	9.93	3.82
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	14.61	3.81
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	10.36	2.16
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	13.34	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	16.82	4.64
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	8.50	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	14.24	3.39
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	16.21	4.63
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	6.34	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	12.01	3.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	16.24	4.81
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	8.75	2.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	12.64	1.61
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	24.66	6.86
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	11.77	4.95
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	13.16	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	12.43	3.82
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	13.08	3.55
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	15.26	6.10
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	14.40	3.32
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	12.18	5.30
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	14.90	5.45
Astrocyte - cerebellum, donor1	11500-119F6	27.02	17.07
Astrocyte - cerebellum, donor2	11580-120F5	28.75	13.01
Astrocyte - cerebellum, donor3	11661-122F5	18.25	4.82
Astrocyte - cerebral cortex, donor1	11235-116D2	27.19	17.08
Astrocyte - cerebral cortex, donor2	11316-117D2	30.74	16.99
Astrocyte - cerebral cortex, donor3	11392-118C6	32.37	16.41
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	21.90	8.49
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	24.68	10.65
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	23.90	8.42
Basophils, donor1	12241-129G9	2.62	1.83
Basophils, donor2	12242-129H1	5.41	0.72
Basophils, donor3	12243-129H2	5.00	2.94
Bronchial Epithelial Cell, donor1	11511-119G8	14.45	12.50
Bronchial Epithelial Cell, donor2	11591-120G7	8.69	2.74
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	15.69	7.53
Bronchial Epithelial Cell, donor5	11457-119A8	19.34	11.44
Bronchial Epithelial Cell, donor6	11461-119B3	13.36	7.14
Bronchial Epithelial Cell, donor7	11769-123I5	12.96	6.48
Burkitt's lymphoma cell line:DAUDI	10422-106C8	28.55	10.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	50.77	2.10
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	16.63	5.12
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	4.51	1.69
CD14+ Monocytes, donor2	11305-117B9	2.41	1.67
CD14+ Monocytes, donor3	11381-118B4	4.83	1.76
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	13.87	11.32
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	12.51	4.17
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	12.82	9.20
CD14+ monocytes - mock treated, donor1	11863-125A9	1.45	2.89
CD14+ monocytes - mock treated, donor2	11873-125C1	0.30	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	1.42	4.03
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	0.50	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	0.83	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	0.50	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	0.39	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	0.18	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	0.22	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	0.94	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	1.06	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	2.22	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	0.15	1.49
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	1.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	0.62	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	0.46	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	0.23	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	0.44	1.75
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	0.54	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	1.22	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	0.84	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	1.32	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	0.35	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	0.74	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	0.86	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	1.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	0.23	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	0.70	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	5.67	3.27
CD14+CD16+ Monocytes, donor2	11801-124D1	3.70	5.31
CD14+CD16+ Monocytes, donor3	11912-125G4	6.50	4.33
CD14+CD16- Monocytes, donor1	11788-124B6	5.76	6.23
CD14+CD16- Monocytes, donor2	11799-124C8	4.72	2.97
CD14+CD16- Monocytes, donor3	11910-125G2	5.35	3.79
CD14-CD16+ Monocytes, donor1	11790-124B8	5.36	3.57
CD14-CD16+ Monocytes, donor2	11800-124C9	4.39	2.63
CD14-CD16+ Monocytes, donor3	11911-125G3	4.84	4.84
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	18.29	10.16
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	8.81	4.07
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	12.43	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	6.40	6.40
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	5.90	2.14
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	6.32	5.62
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	5.49	7.06
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	5.27	6.59
CD19+ B Cells, donor1	11544-120B5	3.29	0.00
CD19+ B Cells, donor2	11624-122B4	4.35	0.00
CD19+ B Cells, donor3	11705-123B4	5.55	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	19.80	16.16
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	24.37	12.38
CD34+ Progenitors, donor1	11545-120B6	2.01	2.01
CD34+ Progenitors, donor2	11625-122B5	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	19.16	10.52
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	16.01	9.24
CD4+ T Cells, donor1	11225-116C1	4.64	3.21
CD4+ T Cells, donor2	11306-117C1	4.29	3.67
CD4+ T Cells, donor3	11382-118B5	8.54	2.44
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	9.44	5.87
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	14.60	9.66
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	15.24	9.49
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	2.84	2.37
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	7.02	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	16.48	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	9.25	6.07
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	16.27	10.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	20.96	10.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	8.07	3.59
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	6.29	3.49
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	3.96	4.40
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	11.38	4.22
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	21.19	11.43
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	19.05	11.69
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	4.62	2.72
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	5.36	2.68
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1.79	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	17.99	14.09
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	20.36	13.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	23.54	15.76
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	3.54	4.04
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	5.20	4.77
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	5.23	1.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	9.40	9.40
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	7.39	3.69
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	18.15	11.17
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	8.58	4.71
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	12.02	5.89
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	13.86	4.62
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	8.24	10.03
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	24.93	8.31
CD8+ T Cells, donor1	11226-116C2	6.22	5.89
CD8+ T Cells, donor2	11307-117C2	8.26	2.25
CD8+ T Cells, donor3	11383-118B6	6.82	2.78
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	25.46	10.78
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	25.16	9.83
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	25.17	13.95
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	23.12	6.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	26.88	12.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	24.79	9.78
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	34.55	11.52
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	31.85	9.74
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	33.77	12.19
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	25.66	12.38
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	27.60	14.23
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	31.17	14.39
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	15.32	6.13
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	15.03	6.83
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	17.16	11.19
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	27.01	11.89
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	29.92	9.21
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	30.40	9.43
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	35.18	15.21
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	30.76	12.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	32.38	11.22
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	21.42	9.94
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	27.19	13.01
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	20.42	10.59
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	8.03	9.64
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	17.49	7.69
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	26.05	6.01
Cardiac Myocyte, donor1	11525-119I4	9.14	3.66
Cardiac Myocyte, donor2	11605-120I3	17.29	5.93
Cardiac Myocyte, donor3	11686-122I3	17.26	11.15
Chondrocyte - de diff, donor1	11261-116G1	39.17	21.84
Chondrocyte - de diff, donor2	11338-117F6	20.97	12.44
Chondrocyte - de diff, donor3	11410-118E6	20.14	12.63
Chondrocyte - re diff, donor2	11339-117F7	39.39	15.22
Chondrocyte - re diff, donor3	11411-118E7	26.29	8.09
Ciliary Epithelial Cells, donor1	11242-116D9	22.26	12.85
Ciliary Epithelial Cells, donor2	11323-117D9	22.23	13.04
Ciliary Epithelial Cells, donor3	11399-118D4	20.97	9.03
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	31.09	18.62
Corneal Epithelial Cells, donor1	11526-119I5	18.44	14.49
Corneal Epithelial Cells, donor2	11606-120I4	13.65	6.83
Corneal Epithelial Cells, donor3	11687-122I4	20.45	11.25
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	19.32	9.25
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	24.60	7.57
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	17.93	9.50
Dendritic Cells - plasmacytoid, donor1	11228-116C4	10.59	3.76
Dendritic Cells - plasmacytoid, donor2	11309-117C4	9.14	2.61
Dendritic Cells - plasmacytoid, donor3	11385-118B8	10.65	1.45
Endothelial Cells - Aortic, donor0	11207-116A1	16.01	7.34
Endothelial Cells - Aortic, donor1	11263-116G3	15.26	8.80
Endothelial Cells - Aortic, donor2	11340-117F8	19.23	15.27
Endothelial Cells - Aortic, donor3	11412-118E8	15.33	14.15
Endothelial Cells - Artery, donor1	11264-116G4	18.62	11.05
Endothelial Cells - Artery, donor2	11341-117F9	19.29	11.76
Endothelial Cells - Artery, donor3	11413-118E9	23.49	15.95
Endothelial Cells - Lymphatic, donor1	11236-116D3	21.06	11.97
Endothelial Cells - Lymphatic, donor2	11317-117D3	23.73	14.60
Endothelial Cells - Lymphatic, donor3	11393-118C7	21.14	7.33
Endothelial Cells - Microvascular, donor1	11265-116G5	14.56	10.10
Endothelial Cells - Microvascular, donor2	11342-117G1	18.22	8.85
Endothelial Cells - Microvascular, donor3	11414-118F1	12.34	7.51
Endothelial Cells - Thoracic, donor1	11266-116G6	27.21	19.61
Endothelial Cells - Thoracic, donor2	11343-117G2	16.25	7.86
Endothelial Cells - Umbilical vein, donor1	11243-116E1	35.91	21.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	18.25	9.99
Endothelial Cells - Umbilical vein, donor3	11400-118D5	23.45	12.58
Endothelial Cells - Vein, donor1	11267-116G7	7.96	7.96
Endothelial Cells - Vein, donor2	11344-117G3	19.56	11.18
Endothelial Cells - Vein, donor3	11416-118F3	23.71	16.80
Eosinophils, donor1	12244-129H3	0.00	0.00
Eosinophils, donor2	12245-129H4	1.65	1.65
Eosinophils, donor3	12246-129H5	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	11.97	12.95
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	10.40
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	30.38	15.60
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	15.77	7.88
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	21.88	8.45
Fibroblast - Aortic Adventitial, donor1	11245-116E3	24.01	15.65
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	9.69	5.19
Fibroblast - Aortic Adventitial, donor2	11326-117E3	16.24	9.49
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	18.44	10.54
Fibroblast - Aortic Adventitial, donor3	11401-118D6	32.56	17.27
Fibroblast - Cardiac, donor1	11268-116G8	22.23	5.90
Fibroblast - Cardiac, donor2	11345-117G4	19.71	9.10
Fibroblast - Cardiac, donor3	11417-118F4	16.72	10.09
Fibroblast - Cardiac, donor4	11452-119A3	28.19	13.94
Fibroblast - Cardiac, donor5	11456-119A7	17.89	7.99
Fibroblast - Cardiac, donor6	11460-119B2	25.47	15.31
Fibroblast - Choroid Plexus, donor1	11492-119E7	30.28	14.74
Fibroblast - Choroid Plexus, donor2	11572-120E6	19.85	6.90
Fibroblast - Choroid Plexus, donor3	11653-122E6	36.62	8.79
Fibroblast - Conjunctival, donor1	11531-120A1	14.07	9.69
Fibroblast - Conjunctival, donor3	11692-122I9	14.59	0.85
Fibroblast - Dermal, donor1	11269-116G9	20.43	10.33
Fibroblast - Dermal, donor2	11346-117G5	20.28	12.74
Fibroblast - Dermal, donor3	11418-118F5	19.95	11.85
Fibroblast - Dermal, donor4	11450-119A1	27.24	15.71
Fibroblast - Dermal, donor5	11454-119A5	28.61	10.12
Fibroblast - Dermal, donor6	11458-119A9	38.49	10.72
Fibroblast - Gingival, donor1	11237-116D4	29.99	13.95
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	23.06	13.62
Fibroblast - Gingival, donor2	11318-117D4	33.87	18.98
Fibroblast - Gingival, donor3	11394-118C8	21.66	10.35
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	33.24	15.58
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	23.26	13.22
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	35.70	16.99
Fibroblast - Gingival, donor6 (control)	11922-125H5	27.99	14.33
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	33.88	16.59
Fibroblast - Gingival, donor7 (control)	11924-125H7	31.00	13.60
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	28.23	13.64
Fibroblast - Gingival, donor8 (control)	11926-125H9	42.89	22.05
Fibroblast - Gingival, donor9 (control)	11927-125I1	17.17	9.24
Fibroblast - Lung, donor1	11270-116H1	10.87	8.16
Fibroblast - Lung, donor2	11347-117G6	14.92	7.46
Fibroblast - Lung, donor3	11419-118F6	29.76	15.41
Fibroblast - Lymphatic, donor1	11506-119G3	41.65	28.32
Fibroblast - Lymphatic, donor2	11586-120G2	26.57	12.59
Fibroblast - Lymphatic, donor3	11667-122G2	17.35	6.44
Fibroblast - Mammary, donor1	11540-120B1	61.71	34.51
Fibroblast - Mammary, donor2	11620-122A9	35.95	7.99
Fibroblast - Mammary, donor3	11701-123A9	47.65	17.87
Fibroblast - Periodontal Ligament, donor1	11238-116D5	32.20	18.62
Fibroblast - Periodontal Ligament, donor2	11319-117D5	40.95	10.31
Fibroblast - Periodontal Ligament, donor3	11395-118C9	45.29	19.58
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	26.33	12.59
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	27.00	12.69
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	28.30	16.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	28.08	15.14
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	73.35	24.38
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	37.42	5.35
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	17.40	3.16
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	24.21	11.51
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	19.01	8.17
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	21.68	11.23
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	21.06	6.92
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	17.60	10.90
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	10.88	3.54
Fibroblast - skin normal, donor1	11553-120C5	22.64	10.83
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	32.68	16.64
Fibroblast - skin normal, donor2	11561-120D4	17.88	11.15
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	12.09	5.74
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	24.69	12.43
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	21.03	7.35
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	21.02	8.54
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	24.93	14.17
Fibroblast - skin walker warburg, donor1	11554-120C6	30.53	17.71
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	11.13	3.45
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	88.64	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	26.15	16.56
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	19.07	17.68
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	21.86	17.18
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	24.78	18.14
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	42.87	21.44
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	44.03	17.87
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	43.36	23.11
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	59.01	36.40
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	34.02	21.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	56.47	28.13
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	55.51	34.10
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	37.83	19.24
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	38.92	19.46
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	28.12	25.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	22.17	20.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	25.25	23.64
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	23.91	15.61
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	25.75	16.47
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	20.13	13.82
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	23.73	12.78
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	22.05	13.08
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	21.20	11.15
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	27.48	12.71
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	24.64	12.56
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	25.92	14.52
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	27.83	11.90
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	21.88	14.08
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	30.50	19.69
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	24.97	15.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	19.98	12.81
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	21.91	13.61
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	28.12	17.47
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	24.50	12.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	18.36	12.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	20.41	13.14
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	24.68	13.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	17.19	10.14
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	17.46	11.93
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	23.67	12.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	19.56	10.90
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	19.24	12.51
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	23.57	14.71
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	18.85	10.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	20.07	12.86
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	21.96	9.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	24.97	8.42
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	23.24	14.63
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	31.29	13.37
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	25.86	15.76
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	25.39	21.89
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	25.21	17.62
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	21.20	12.72
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	24.78	13.82
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	22.81	16.86
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	22.69	14.25
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	23.40	12.91
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	43.46	26.18
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	22.69	22.29
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	24.04	29.74
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	31.71	40.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	63.84	50.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	50.01	40.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	27.67	40.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	34.65	29.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	36.75	27.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	54.55	27.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	39.99	31.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	36.45	23.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	32.12	25.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	46.65	19.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	30.20	27.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	35.30	22.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	32.71	21.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	32.44	19.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	31.93	19.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	25.06	25.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	30.93	14.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	29.30	17.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	20.33	15.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	32.31	23.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	31.53	26.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	21.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	24.22	18.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	29.66	14.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	21.40	19.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	23.50	8.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	28.41	21.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	19.88	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	25.95	10.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	29.57	6.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	21.87	12.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	26.32	13.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	23.19	8.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	33.05	11.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	23.92	9.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	24.58	4.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	20.34	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	23.28	10.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	16.50	5.82
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	17.12	6.85
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	19.13	6.24
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	31.48	22.49
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	13.96	7.93
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	15.87	6.27
Hep-2 cells mock treated, biol_rep1	11898-125E8	24.25	17.17
Hep-2 cells mock treated, biol_rep2	11899-125E9	33.09	15.70
Hep-2 cells mock treated, biol_rep3	11900-125F1	28.44	16.38
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	23.61	19.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	24.50	17.41
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	31.86	17.01
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	23.54	14.70
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	26.93	13.38
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	17.62	10.25
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	16.79	10.07
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	24.24	17.31
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	10.58	7.93
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	32.80	18.69
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	20.34	10.90
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	22.55	14.86
Hepatocyte, donor1	11523-119I2	9.68	2.42
Hepatocyte, donor2	11603-120I1	9.70	14.01
Hepatocyte, donor3	11684-122I1	14.11	4.91
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	28.72	9.79
Intestinal epithelial cells (polarized), donor1	11246-116E4	27.97	30.41
Iris Pigment Epithelial Cells, donor1	11530-119I9	16.33	8.23
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	22.29	9.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	15.23	9.69
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	17.94	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	22.85
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	21.12	17.87
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	6.67	6.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	14.52
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	15.88	13.23
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	16.63	13.30
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	10.48
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	8.19	11.34
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	26.29	7.73
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	17.44	16.15
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	11.27	8.05
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	35.84
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	14.67	19.56
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	14.69	12.17
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	16.07	16.88
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	12.00	9.23
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	14.16	19.35
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	13.60	6.35
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	16.14	20.45
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	19.06	20.33
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	15.30	12.12
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	12.76	5.47
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	15.71	13.57
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	9.95
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	15.12	20.06
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	8.78	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	15.72	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	15.30	17.38
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	19.92	13.28
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	12.97
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	15.69	15.69
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	20.25	13.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	13.94
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	30.94	18.14
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	11.08	18.01
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	31.35	17.10
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	8.28	12.89
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	12.42
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	19.03	16.92
Keratinocyte - epidermal, donor1	11272-116H3	21.71	12.32
Keratinocyte - epidermal, donor2	11349-117G8	7.03	2.34
Keratinocyte - epidermal, donor3	11421-118F8	25.94	16.38
Keratinocyte - oral, donor1	11251-116E9	18.05	12.26
Keratocytes, donor1	11527-119I6	9.28	8.25
Keratocytes, donor2	11607-120I5	24.61	10.55
Keratocytes, donor3	11688-122I5	11.66	3.56
Krukenberg tumor cell line:HSKTC	10687-109F3	32.97	4.40
Lens Epithelial Cells, donor1	11529-119I8	11.87	11.87
Lens Epithelial Cells, donor2	11609-120I7	13.96	0.46
Lens Epithelial Cells, donor3	11690-122I7	14.63	5.65
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	20.16	10.79
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	10.88	3.35
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	17.32	11.49
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	12.37	8.07
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	10.40	4.10
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	10.13	8.30
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	9.85	6.98
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	9.10	2.28
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	11.40	7.04
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	7.91	5.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	9.50	2.52
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	9.44	8.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	11.85	5.92
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	11.93	3.10
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	12.50	7.97
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	12.63	6.78
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	10.60	2.81
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	10.43	11.89
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	10.53	5.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	10.54	3.22
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	8.21	4.23
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	8.73	6.30
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	10.50	4.31
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	11.35	7.87
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	12.44	7.78
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	9.42	3.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	9.62	9.47
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	8.25	9.63
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	8.47	4.52
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	12.94	9.01
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	9.21	5.81
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	7.61	4.63
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	11.40	6.44
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	10.74	6.66
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	11.12	5.44
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	10.31	7.56
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	9.01	6.43
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	6.39	5.48
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	14.42	11.20
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	11.02	7.47
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	11.15	2.91
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	9.49	8.40
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	11.46	7.52
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	11.11	5.55
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.94	8.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	16.95	14.23
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.43	4.10
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	14.02	6.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	18.13	13.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	13.81	9.21
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	25.24	14.84
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	17.35	13.12
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	23.91	8.44
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	8.41	8.41
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	16.49	9.79
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	11.89	3.57
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	14.93	12.67
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	15.12	13.96
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	17.11	13.96
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	21.95	17.07
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	17.46	13.87
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	14.47	12.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	14.66	13.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	23.43	11.72
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	17.61	10.14
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	20.78	14.55
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	22.09	11.66
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	17.12	8.15
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	16.87	16.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	20.18	13.17
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	24.73	14.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	21.48	13.93
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	24.81	12.26
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	21.58	14.38
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	21.21	13.79
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	16.96	9.96
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	14.97	5.76
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	21.11	11.51
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	19.25	11.89
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	15.59	6.56
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	14.46	14.46
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	17.95	15.08
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	14.94	16.43
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	19.32	12.26
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	18.09	9.91
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	16.27	14.56
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	15.66	14.99
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	15.08	13.88
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	14.22	11.38
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	17.53	12.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	19.32	12.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	19.53	11.45
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	21.11	15.93
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	11.63	13.96
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	12.69	14.81
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	23.61	11.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	26.17	18.17
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	14.56	9.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	14.80	15.78
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	13.17	8.47
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	23.63	13.07
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	17.57	14.87
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	20.65	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	15.59	16.03
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	15.25	14.86
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	16.49	8.58
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	19.72	10.38
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	17.50	10.50
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	12.30	7.83
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	14.13	13.69
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	16.97	15.43
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	15.70	16.71
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	20.19	15.38
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	21.87	15.11
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	15.19	5.47
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	11.07	7.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	14.44	10.64
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	17.56	14.46
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	12.09	10.28
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	18.38	14.26
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	18.13	7.46
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	12.64	8.05
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	24.17	15.43
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	18.39	13.44
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	10.78	12.48
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	17.89	15.39
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	16.44	7.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	12.94	9.19
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	21.37	13.94
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	20.74	5.35
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	13.90	11.23
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	15.76	13.34
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	25.70	18.36
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	4.45	9.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	22.79	17.67
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	13.80	12.27
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	12.59	7.66
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	21.83	19.60
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	26.78	21.06
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	11.94	9.28
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	27.02	14.55
Macrophage - monocyte derived, donor1	11232-116C8	14.36	7.98
Macrophage - monocyte derived, donor2	11313-117C8	19.08	5.32
Macrophage - monocyte derived, donor3	11389-118C3	25.04	14.29
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	11.68	12.74
Mallassez-derived cells, donor2	11929-125I3	14.42	12.68
Mallassez-derived cells, donor3	11930-125I4	14.73	10.01
Mammary Epithelial Cell, donor1	11273-116H4	18.83	10.16
Mammary Epithelial Cell, donor2	11350-117G9	14.77	10.42
Mammary Epithelial Cell, donor3	11422-118F9	27.44	14.97
Mast cell - stimulated, donor1	11487-119E2	9.49	4.75
Mast cell, donor1	11563-120D6	14.92	11.46
Mast cell, donor2	11565-120D8	8.02	5.35
Mast cell, donor3	11566-120D9	4.28	4.50
Mast cell, donor4	11567-120E1	8.51	4.25
Mast cell, expanded and stimulated, donor5	11940-126A5	17.08	8.65
Mast cell, expanded and stimulated, donor8	11942-126A7	15.18	10.51
Mast cell, expanded, donor5	11939-126A4	16.41	7.69
Mast cell, expanded, donor8	11941-126A6	19.58	12.22
Melanocyte - dark, donor1	11502-119F8	24.77	16.91
Melanocyte - dark, donor2	11582-120F7	10.04	8.31
Melanocyte - dark, donor3	11663-122F7	64.47	43.61
Melanocyte - light, donor1	11274-116H5	31.97	15.98
Melanocyte - light, donor2	11351-117H1	19.79	10.92
Melanocyte - light, donor3	11423-118G1	21.68	9.54
Melanocyte, donor1 (MC+1)	12641-134G4	59.46	20.72
Melanocyte, donor2 (MC+2)	12739-135I3	42.76	31.20
Melanocyte, donor3 (MC+3)	12837-137B2	26.25	17.41
Meningeal Cells, donor1	11493-119E8	53.72	32.75
Meningeal Cells, donor2	11573-120E7	35.21	19.37
Meningeal Cells, donor3	11654-122E7	42.79	26.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	21.96	13.12
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	24.76	9.56
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	6.57	5.26
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	11.77	11.77
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	33.01	15.07
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	25.62	12.07
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	19.10	10.05
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	37.14	19.34
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	47.49	17.53
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	33.15	20.46
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	12.47	6.93
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	15.98	10.04
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	24.74	11.97
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	13.95	6.23
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	4.67
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	28.18	10.89
Mesenchymal stem cells - adipose, donor0	11217-116B2	27.65	22.33
Mesenchymal stem cells - hepatic, donor0	11218-116B3	16.26	10.01
Mesenchymal stem cells - umbilical, donor0	11214-116A8	23.22	10.89
Mesothelial Cells, donor1	11247-116E5	25.99	10.87
Mesothelial Cells, donor2	12156-128G5	19.02	6.01
Mesothelial Cells, donor3	11402-118D7	25.15	13.30
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	12.15	4.05
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	14.04	10.34
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	15.90	10.01
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	6.91
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	12.71	7.44
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	10.99	7.68
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	9.26	4.63
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	15.52	7.51
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	12.10	12.10
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	11.58	5.89
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	17.03	5.54
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	8.85	2.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	10.64	7.98
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	15.79	2.63
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	9.34	3.82
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	11.05	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	10.13	4.77
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	10.04	3.01
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	7.37	6.65
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	3.87	4.42
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	7.37	5.53
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	10.10	5.89
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	9.99	3.67
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	8.15	3.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	8.45	4.89
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	5.69	2.41
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	5.58	3.04
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	6.52	3.26
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	6.76	2.94
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	1.09	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	8.65	2.88
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	6.00	2.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	5.01	1.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	2.63	3.94
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2.21	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	2.56	3.84
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	5.95	4.46
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	3.48	2.09
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	5.47	2.74
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	1.75	1.75
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	3.20	1.42
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	6.45	3.65
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	4.16	2.91
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	4.66	4.08
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	6.03	4.22
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	8.77	4.59
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	6.46	5.54
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	7.40	1.71
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	4.97	4.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	6.48	4.15
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	4.29	4.29
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	4.45	2.54
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	6.67	4.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	10.48	5.39
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	3.96	3.25
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	9.56	5.41
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	7.96	5.53
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	4.55	4.93
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	6.82	5.11
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	8.36	6.88
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	5.21	3.26
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	9.70	7.35
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	7.78	4.61
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	6.18	2.06
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	7.15	3.57
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	7.53
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	3.56	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	12.16	8.54
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	21.04	12.62
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	14.23	9.49
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	9.31	11.18
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	8.64	6.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	14.65	7.46
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	7.01	6.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	10.31	6.63
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	13.92	10.99
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	9.33	6.22
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	3.74	2.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	10.10	4.04
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	7.59	5.90
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.18	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	2.43
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	4.53	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	24.99	10.99
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	17.25	9.93
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	56.74	18.69
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	42.99	16.28
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	28.52	10.65
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	31.92	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	41.48	10.88
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	11.03	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	28.04	13.39
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	46.49	15.34
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	48.37	14.59
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	22.07	6.52
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	31.77	8.93
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	20.57	4.33
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	39.44	9.75
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	33.15	12.41
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	20.96	10.02
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	40.31	13.26
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	27.01	9.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	11.16	2.63
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	37.08	12.52
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	24.34	7.76
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	49.23	12.66
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	35.40	14.25
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	49.17	18.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	17.24	5.52
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	15.17	10.11
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	16.93	8.47
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	44.46	14.82
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	18.99	6.65
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	67.39	21.46
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	40.65	11.66
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	18.94	8.57
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	34.92	11.11
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	52.93	22.29
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	30.65	9.46
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	36.50	14.01
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	36.17	12.64
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	20.35	8.59
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	42.33	23.81
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	38.56	19.95
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	48.12	16.87
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	45.56	14.55
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	35.99	9.38
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	21.66	7.29
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	46.08	13.55
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	62.19	17.68
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	42.80	11.65
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	43.58	7.26
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	41.14	12.66
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	20.41	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	0.00
Myoblast, donor1	11241-116D8	28.82	7.83
Myoblast, donor2	11322-117D8	27.62	12.27
Myoblast, donor3	11398-118D3	30.44	17.66
NK T cell leukemia cell line:KHYG-1	10777-110G3	32.11	14.74
Natural Killer Cells, donor1	11230-116C6	10.15	3.69
Natural Killer Cells, donor2	11311-117C6	4.22	2.71
Natural Killer Cells, donor3	11387-118C1	9.20	3.87
Neural stem cells, donor1	11275-116H6	21.78	11.98
Neural stem cells, donor2	11352-117H2	15.41	23.11
Neurons, donor1	11494-119E9	26.17	12.52
Neurons, donor2	11574-120E8	17.17	9.47
Neurons, donor3	11655-122E8	19.73	7.40
Neutrophils, donor1	11233-116C9	0.00	0.93
Neutrophils, donor2	11314-117C9	0.00	5.80
Neutrophils, donor3	11390-118C4	1.83	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	15.08	6.41
Nucleus Pulposus Cell, donor2	11409-118E5	11.07	5.86
Nucleus Pulposus Cell, donor3	11462-119B4	12.84	3.81
Olfactory epithelial cells, donor1	11933-125I7	21.06	11.43
Olfactory epithelial cells, donor2	11934-125I8	26.92	11.87
Olfactory epithelial cells, donor3	11935-125I9	28.94	11.46
Olfactory epithelial cells, donor4	11936-126A1	34.28	18.02
Oligodendrocyte - precursors, donor1	11496-119F2	30.09	12.64
Osteoblast - differentiated, donor1	11276-116H7	18.29	9.36
Osteoblast - differentiated, donor2	11353-117H3	16.00	11.43
Osteoblast - differentiated, donor3	11425-118G3	15.52	7.45
Osteoblast, donor1	11277-116H8	15.44	6.84
Osteoblast, donor2	11354-117H4	33.71	18.96
Osteoblast, donor3	11426-118G4	31.28	17.60
Pancreatic stromal cells, donor1	11249-116E7	24.18	13.56
Pericytes, donor1	11491-119E6	15.91	8.01
Pericytes, donor2	11571-120E5	13.58	2.04
Pericytes, donor3	11652-122E5	24.62	12.00
Perineurial Cells, donor1	11499-119F5	24.41	13.79
Perineurial Cells, donor2	11579-120F4	17.76	9.94
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	6.06	4.78
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	4.41	2.20
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	5.69	5.18
Placental Epithelial Cells, donor1	11278-116H9	15.07	11.72
Placental Epithelial Cells, donor2	11355-117H5	13.31	5.54
Placental Epithelial Cells, donor3	11427-118G5	19.83	10.60
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	26.27	8.54
Preadipocyte - breast, donor1	11467-119B9	34.33	9.57
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	16.32	5.74
Preadipocyte - breast, donor2	11328-117E5	30.85	14.86
Preadipocyte - omental, donor1	11468-119C1	40.17	20.14
Preadipocyte - omental, donor2	11329-117E6	41.03	17.02
Preadipocyte - omental, donor3	11403-118D8	39.11	15.90
Preadipocyte - perirenal, donor1	11469-119C2	28.54	14.76
Preadipocyte - subcutaneous, donor1	11279-116I1	24.57	9.52
Preadipocyte - subcutaneous, donor2	11356-117H6	43.74	17.18
Preadipocyte - subcutaneous, donor3	11428-118G6	30.48	15.33
Preadipocyte - visceral, donor1	11280-116I2	41.73	24.96
Preadipocyte - visceral, donor2	11357-117H7	19.33	10.12
Preadipocyte - visceral, donor3	11429-118G7	28.32	13.06
Prostate Epithelial Cells (polarized), donor1	11253-116F2	28.96	25.04
Prostate Epithelial Cells, donor2	11331-117E8	17.87	10.56
Prostate Epithelial Cells, donor3	11404-118D9	11.33	10.04
Prostate Stromal Cells, donor1	11254-116F3	37.36	12.30
Prostate Stromal Cells, donor2	11332-117E9	32.99	17.75
Prostate Stromal Cells, donor3	11405-118E1	22.11	10.95
Renal Cortical Epithelial Cells, donor1	11516-119H4	31.02	12.77
Renal Cortical Epithelial Cells, donor2	11596-120H3	23.01	12.75
Renal Epithelial Cells, donor1	11517-119H5	40.07	22.83
Renal Epithelial Cells, donor2	11597-120H4	35.57	29.16
Renal Epithelial Cells, donor3	11678-122H4	26.25	16.62
Renal Glomerular Endothelial Cells, donor1	11514-119H2	18.38	7.49
Renal Glomerular Endothelial Cells, donor2	11594-120H1	27.09	12.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	22.20	14.21
Renal Glomerular Endothelial Cells, donor4	11783-124B1	9.98	5.32
Renal Mesangial Cells, donor1	11518-119H6	34.77	22.01
Renal Mesangial Cells, donor2	11598-120H5	35.11	17.56
Renal Mesangial Cells, donor3	11679-122H5	19.14	11.65
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	45.36	26.57
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	25.30	18.55
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	34.91	21.41
Retinal Pigment Epithelial Cells, donor0	11215-116A9	19.19	1.56
Retinal Pigment Epithelial Cells, donor1	11528-119I7	22.46	12.22
Retinal Pigment Epithelial Cells, donor2	11608-120I6	27.79	17.50
Retinal Pigment Epithelial Cells, donor3	11689-122I6	13.80	9.53
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	22.32	10.82
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	45.56	35.74
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	16.51	7.15
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	19.72	9.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	30.69	18.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	43.60	32.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	60.45	39.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	43.91	25.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	50.70	33.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	48.08	34.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	32.45	13.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	43.26	26.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	55.01	37.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	33.86	18.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	43.14	25.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	46.69	30.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	29.63	9.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	40.81	23.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	57.12	40.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	27.74	14.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	41.08	25.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	51.37	33.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	31.72	15.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	42.33	24.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	51.78	30.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	30.08	16.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	41.33	28.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	56.01	35.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	36.80	16.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	36.90	29.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	63.14	35.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	36.91	16.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	36.72	26.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	57.65	32.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	37.01	24.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	32.70	26.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	48.58	42.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	31.29	18.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	38.41	23.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	49.09	30.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	32.04	12.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	49.86	29.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	43.45	31.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	27.38	16.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	48.81	28.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	54.21	26.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	29.38	17.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	43.67	19.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	33.55	26.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	30.47	16.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	44.68	40.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	51.11	43.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	35.26	18.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	59.04	48.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	61.41	47.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	36.84	27.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	60.19	55.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	59.50	46.88
Schwann Cells, donor1	11498-119F4	25.95	12.22
Schwann Cells, donor2	11578-120F3	27.22	10.21
Schwann Cells, donor3	11659-122F3	24.76	1.10
Sebocyte, donor1	11220-116B5	38.34	20.82
Sebocyte, donor2	11301-117B5	16.54	6.43
Sebocyte, donor3	11378-118B1	20.20	11.95
Sertoli Cells, donor1	11255-116F4	16.57	14.91
Sertoli Cells, donor2	11333-117F1	8.47	5.65
Skeletal Muscle Cells, donor1	11281-116I3	17.77	12.40
Skeletal Muscle Cells, donor2	11358-117H8	10.84	2.89
Skeletal Muscle Cells, donor3	11430-118G8	35.11	11.70
Skeletal Muscle Cells, donor4	11451-119A2	26.23	12.10
Skeletal Muscle Cells, donor5	11455-119A6	21.85	11.30
Skeletal Muscle Cells, donor6	11459-119B1	28.32	7.85
Skeletal Muscle Satellite Cells, donor1	11240-116D7	19.78	9.20
Skeletal Muscle Satellite Cells, donor2	11321-117D7	18.41	8.28
Skeletal Muscle Satellite Cells, donor3	11397-118D2	38.49	18.16
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	23.42	13.06
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	21.71	14.48
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	13.76	3.03
Skin - palm, donor1	10286-104F7	16.12	10.74
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	17.30	4.47
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	9.00	6.54
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	18.57	8.70
Small Airway Epithelial Cells, donor1	11256-116F5	11.12	5.98
Small Airway Epithelial Cells, donor2	11334-117F2	13.78	7.17
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	17.34	11.42
Small Airway Epithelial Cells, donor3	11406-118E2	11.39	8.92
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	8.33	4.94
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	18.45	7.78
Smooth Muscle Cells - Aortic, donor0	11210-116A4	25.28	10.58
Smooth Muscle Cells - Aortic, donor1	11283-116I5	14.36	8.18
Smooth Muscle Cells - Aortic, donor2	11360-117I1	24.02	11.81
Smooth Muscle Cells - Aortic, donor3	11432-118H1	32.45	13.13
Smooth Muscle Cells - Bladder, donor1	11519-119H7	10.01	7.01
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	18.23	12.78
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	27.04	13.08
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	23.30	12.93
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	25.07	11.40
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	35.14	16.24
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	23.35	10.53
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	28.14	13.01
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	10.35	5.48
Smooth Muscle Cells - Carotid, donor1	11285-116I7	24.75	11.87
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	11.92	5.72
Smooth Muscle Cells - Colonic, donor1	11239-116D6	18.43	4.42
Smooth Muscle Cells - Colonic, donor2	11320-117D6	19.80	7.96
Smooth Muscle Cells - Colonic, donor3	11396-118D1	24.46	12.18
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	24.59	13.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	17.25	9.70
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	21.22	9.86
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	26.63	16.05
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	14.06	5.97
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	29.49	12.48
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	25.03	15.47
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	16.91	6.04
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	42.12	24.37
Smooth Muscle Cells - Prostate, donor1	11257-116F6	25.70	11.32
Smooth Muscle Cells - Prostate, donor2	11335-117F3	19.16	10.27
Smooth Muscle Cells - Prostate, donor3	11465-119B7	19.28	13.19
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	34.07	14.93
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	24.76	12.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	21.97	20.68
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	29.76	19.07
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	21.71	9.09
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	18.80	13.48
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	16.22	12.39
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	34.24	19.16
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	17.28	7.01
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	20.58	16.41
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	18.36	15.55
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	22.19	12.22
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	15.65	9.22
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	15.00	6.37
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	12.38	2.38
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	20.55	12.48
Smooth Muscle Cells - Uterine, donor1	11258-116F7	18.34	8.18
Smooth Muscle Cells - Uterine, donor3	11466-119B8	15.80	8.19
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	15.94	7.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	13.75	5.82
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	4.46	3.72
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	20.48	10.06
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	15.61	10.50
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	19.30	8.67
Smooth muscle cells - airway, control, donor1	11966-126D4	14.98	6.09
Smooth muscle cells - airway, control, donor2	11967-126D5	13.98	4.79
Smooth muscle cells - airway, control, donor3	11968-126D6	18.81	7.94
Smooth muscle cells - airway, control, donor4	11969-126D7	10.54	7.33
Synoviocyte, donor1	11291-117A4	24.57	17.34
Synoviocyte, donor2	11368-117I9	23.64	15.09
Synoviocyte, donor3	11440-118H9	17.65	13.63
Trabecular Meshwork Cells, donor1	11532-120A2	46.81	32.16
Trabecular Meshwork Cells, donor2	11612-122A1	13.87	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	24.31	11.58
Tracheal Epithelial Cells, donor1	11292-117A5	19.07	11.90
Tracheal Epithelial Cells, donor2	11369-118A1	16.24	5.80
Tracheal Epithelial Cells, donor3	11441-118I1	17.75	6.30
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	21.16	10.09
Urethra, donor2	10319-105A4	19.78	7.19
Urothelial Cells, donor1	11520-119H8	19.13	14.61
Urothelial Cells, donor2	11600-120H7	16.42	10.01
Urothelial Cells, donor3	11681-122H7	17.65	9.17
Urothelial cells, donor0	11216-116B1	20.51	10.25
Whole blood (ribopure), donor090309, donation1	12179-129A1	6.23	7.12
Whole blood (ribopure), donor090309, donation2	12180-129A2	1.43	8.58
Whole blood (ribopure), donor090309, donation3	12181-129A3	4.79	5.48
Whole blood (ribopure), donor090325, donation1	12176-128I7	8.95	5.51
Whole blood (ribopure), donor090325, donation2	12177-128I8	8.13	8.13
Whole blood (ribopure), donor090612, donation1	12182-129A4	4.16	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	2.75	2.75
Whole blood (ribopure), donor090612, donation3	12184-129A6	2.74	5.48
Wilms' tumor cell line:G-401	10809-111A8	33.80	24.30
Wilms' tumor cell line:HFWT	10597-108E3	9.68	7.92
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	33.24	19.55
achilles tendon, donor2	10292-104G4	0.00	8.27
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	24.48	17.08
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	32.27	16.95
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	28.02	14.13
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	50.61	31.29
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	31.76	19.39
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	22.42	12.27
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	23.68	10.62
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	18.95	9.25
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	23.68	9.80
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	35.34	13.59
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	36.25	19.69
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	19.50	15.60
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	26.72	19.75
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	37.28	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	31.85	2.05
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	10.69	5.58
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	13.98	7.40
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	58.93	21.18
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	41.82	20.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	33.06	16.68
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	34.18	21.90
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	20.49	15.59
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	27.35	13.68
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	18.58	9.29
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	20.34	11.68
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	18.75	6.11
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	13.12	7.50
adenocarcinoma cell line:IM95m	10796-110I4	42.63	26.85
adipose tissue, adult, pool1	10010-101C1	18.15	13.96
adipose, donor1	10184-103D4	22.87	13.49
adipose, donor2	10185-103D5	23.52	16.63
adipose, donor3	10186-103D6	31.86	17.97
adipose, donor4	10187-103D7	29.47	19.07
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	32.04	17.83
adrenal gland, adult, pool1	10081-102A9	25.46	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	24.28	12.01
alveolar cell carcinoma cell line:SW 1573	10708-109H6	26.44	15.72
amniotic membrane cells, donor1	12235-129G3	25.74	13.91
amniotic membrane cells, donor2	12236-129G4	42.60	17.58
amniotic membrane cells, donor3	12237-129G5	13.55	8.54
amygdala - adult, donor10196	10167-103B5	14.23	4.74
amygdala, adult, donor10252	10151-102I7	17.44	7.10
amygdala, newborn, donor10223	10360-105E9	11.62	4.20
anaplastic carcinoma cell line:8305C	10428-106D5	19.23	5.48
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	77.88	56.26
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	32.07	7.68
aorta, adult, pool1	10052-101G7	31.77	8.24
appendix, adult	10189-103D9	20.18	12.03
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	15.48	16.16
artery, adult	10190-103E1	27.17	23.10
astrocytoma cell line:TM-31	10425-106D2	31.44	29.70
b cell line:RPMI1788	10427-106D4	11.15	6.99
basal cell carcinoma cell line:TE 354.T	10702-109G9	30.52	13.04
bile duct carcinoma cell line:HuCCT1	10432-106D9	23.52	21.83
bile duct carcinoma cell line:TFK-1	10496-107C1	12.72	12.22
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	12.86	6.71
bladder, adult, pool1	10011-101C2	19.01	4.78
blood, adult, pool1	10053-101G8	8.86	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	19.70	9.42
bone marrow, adult	10192-103E3	16.20	10.80
brain, adult, donor1	10084-102B3	19.48	23.58
brain, adult, pool1	10012-101C3	11.69	7.91
brain, fetal, pool1	10085-102B4	13.36	18.70
breast carcinoma cell line:MCF7	10482-107A5	11.89	5.62
breast carcinoma cell line:MDA-MB-453	10419-106C5	25.21	18.35
breast, adult, donor1	10080-102A8	36.62	23.36
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	32.39	16.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	32.47	22.57
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	23.94	3.91
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	38.25	30.26
carcinoid cell line:NCI-H1770	10703-109H1	33.85	19.75
carcinoid cell line:NCI-H727	10735-110B6	18.16	12.58
carcinoid cell line:SK-PN-DW	10719-109I8	26.62	12.68
carcinosarcoma cell line:JHUCS-1	10642-109A3	51.37	26.88
caudate nucleus - adult, donor10196	10177-103C6	27.63	11.51
caudate nucleus, adult, donor10252	10164-103B2	21.08	8.03
caudate nucleus, adult, donor10258	10379-105H1	46.61	14.52
caudate nucleus, newborn, donor10223	10354-105E3	14.65	6.59
cerebellum - adult, donor10196	10173-103C2	43.70	11.65
cerebellum, adult, donor10252	10166-103B4	28.40	7.26
cerebellum, adult, pool1	10083-102B2	36.56	13.80
cerebellum, newborn, donor10223	10357-105E6	18.27	7.47
cerebral meninges, adult	10188-103D8	10.84	7.06
cerebrospinal fluid, donor2	10294-104G6	13.89	10.96
cervical cancer cell line:D98-AH2	10552-107I3	48.31	45.00
cervical cancer cell line:ME-180	10553-107I4	17.07	16.41
cervix, adult, pool1	10013-101C4	23.31	12.60
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	59.22	42.22
chondrosarcoma cell line:SW 1353	10700-109G7	5.23	1.31
choriocarcinoma cell line:BeWo	10423-106C9	18.89	12.80
choriocarcinoma cell line:SCH	10785-110H2	36.35	24.15
choriocarcinoma cell line:T3M-3	10618-108G6	16.84	8.30
chorionic membrane cells, donor1	12238-129G6	22.51	9.12
chorionic membrane cells, donor2	12239-129G7	35.00	18.00
chorionic membrane cells, donor3	12240-129G8	16.48	8.24
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	18.18	9.09
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	22.28	7.11
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	17.32	12.67
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	23.63	6.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	18.14	8.95
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	17.51	10.18
chronic myelogenous leukemia cell line:K562	10454-106G4	27.97	14.13
chronic myelogenous leukemia cell line:KU812	10409-106B4	27.37	14.60
clear cell carcinoma cell line:JHOC-5	10638-108I8	15.77	6.17
clear cell carcinoma cell line:TEN	10636-108I6	29.32	12.49
colon carcinoma cell line:CACO-2	10513-107D9	41.00	27.82
colon carcinoma cell line:COLO-320	10420-106C6	22.04	13.30
colon, adult, donor1	10082-102B1	33.32	21.42
colon, adult, pool1	10014-101C5	24.68	15.98
colon, fetal, donor1	10070-101I7	14.21	8.65
common myeloid progenitor CMP, donor1	12130-128D6	13.75	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	31.45	11.05
cord blood derived cell line:COBL-a 24h infection	10453-106G3	38.03	20.68
cord blood derived cell line:COBL-a untreated	10449-106F8	48.08	21.29
corpus callosum, adult, pool1	10042-101F6	25.87	13.49
cruciate ligament, donor2	10295-104G7	11.35	6.48
diaphragm, fetal, donor1	10069-101I6	44.14	14.45
diencephalon, adult	10193-103E4	23.76	9.12
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	6.66	4.36
ductal cell carcinoma cell line:KLM-1	10438-106E6	36.41	26.41
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	27.68	13.00
ductus deferens, adult	10196-103E7	21.43	9.47
duodenum, fetal, donor1, tech_rep1	10071-101I8	33.13	5.76
duodenum, fetal, donor1, tech_rep2	10071-101I8	13.24	4.41
dura mater, adult, donor1	10041-101F5	27.83	16.43
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	47.52	31.98
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	59.47	36.11
embryonic pancreas cell line:1B2C6	10604-108F1	11.10	3.70
embryonic pancreas cell line:1C3D3	10605-108F2	13.02	6.36
embryonic pancreas cell line:1C3IKEI	10606-108F3	11.73	6.79
embryonic pancreas cell line:2C6	10603-108E9	9.19	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	24.13	7.71
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	26.46	12.14
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	23.96	14.79
epidermoid carcinoma cell line:A431	10426-106D3	19.12	15.34
epidermoid carcinoma cell line:Ca Ski	10431-106D8	32.78	19.58
epididymis, adult	10197-103E8	22.19	15.07
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	25.55	9.23
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	16.52	7.47
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	41.54	21.62
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	43.90	26.38
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	50.30	26.21
esophagus, adult, pool1	10015-101C6	22.40	14.76
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	23.04	8.02
eye - muscle inferior rectus, donor1	10272-104E2	26.56	21.73
eye - muscle lateral, donor2	10298-104H1	16.83	6.31
eye - muscle medial, donor2	10299-104H2	29.76	29.76
eye - muscle superior, donor2	10297-104G9	20.64	14.90
eye - vitreous humor, donor1	10268-104D7	8.74	8.74
eye, fetal, donor1	10054-101G9	24.66	19.83
fibrosarcoma cell line:HT-1080	10758-110E2	23.72	17.18
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	28.73	13.77
frontal lobe, adult, pool1	10040-101F4	22.99	12.48
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	44.44	41.43
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	19.93	14.63
gall bladder, adult	10198-103E9	23.90	14.24
gamma delta positive T cells, donor1	11937-126A2	19.86	7.52
gamma delta positive T cells, donor2	11938-126A3	17.93	9.34
gastric adenocarcinoma cell line:MKN1	10614-108G2	29.15	12.88
gastric adenocarcinoma cell line:MKN45	10612-108F9	24.95	15.09
gastric cancer cell line:AZ521	10549-107H9	14.10	8.03
gastric cancer cell line:GSS	10560-108A2	9.15	8.24
gastrointestinal carcinoma cell line:ECC12	10615-108G3	29.01	19.42
giant cell carcinoma cell line:LU65	10487-107B1	25.36	12.74
giant cell carcinoma cell line:Lu99B	10433-106E1	9.24	2.66
glassy cell carcinoma cell line:HOKUG	10688-109F4	15.71	13.72
glioblastoma cell line:A172, tech_rep1	10444-106F3	18.05	8.02
glioblastoma cell line:A172, tech_rep2	10444-106F3	18.12	7.02
glioblastoma cell line:T98G	10485-107A8	29.58	6.29
glioma cell line:GI-1	10413-106B8	17.87	14.35
globus pallidus - adult, donor10196	10175-103C4	31.34	9.48
globus pallidus, adult, donor10252	10161-103A8	26.12	8.06
globus pallidus, adult, donor10258	10367-105F7	5.48	1.37
globus pallidus, newborn, donor10223	10364-105F4	21.85	9.59
granulocyte macrophage progenitor, donor1	12131-128D7	41.60	17.13
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	25.28	11.84
hIPS +CCl2, biol_rep1	14383-156B9	23.41	14.23
hIPS +CCl2, biol_rep2	14384-156C1	16.46	10.06
hIPS +CCl2, biol_rep3	14385-156C2	31.56	14.81
hIPS, biol_rep1	14380-156B6	28.75	10.06
hIPS, biol_rep2	14381-156B7	24.01	9.60
hIPS, biol_rep3	14382-156B8	18.76	3.31
hairy cell leukemia cell line:Mo	10712-109I1	25.86	9.77
heart - mitral valve, adult	10205-103F7	18.54	11.36
heart - pulmonic valve, adult	10206-103F8	17.78	11.77
heart - tricuspid valve, adult	10207-103F9	16.65	8.33
heart, adult, diseased post-infarction, donor1	10050-101G5	50.81	37.14
heart, adult, diseased, donor1	10051-101G6	38.32	31.94
heart, adult, pool1	10016-101C7	26.91	14.95
heart, fetal, pool1	10046-101G1	28.03	22.79
hepatic mesenchymal tumor cell line:LI90	10778-110G4	33.32	17.89
hepatoblastoma cell line:HuH-6	10633-108I3	26.16	11.89
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	36.35	20.66
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	39.20	18.69
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	36.38	19.10
hepatoma cell line:Li-7	10484-107A7	13.90	11.01
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	45.93	26.43
hippocampus - adult, donor10196	10169-103B7	15.14	5.68
hippocampus, adult, donor10252	10153-102I9	17.14	6.94
hippocampus, adult, donor10258	10374-105G5	8.96	2.99
hippocampus, newborn, donor10223	10363-105F3	15.51	9.87
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	45.78	34.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	45.75	26.31
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	37.32	23.10
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	49.06	28.19
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	50.35	33.31
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	42.90	34.16
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	26.86	18.39
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	44.59	25.21
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	31.70	25.44
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	30.07	26.28
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	34.23	26.52
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	41.07	27.61
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	39.90	25.51
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	33.41	11.79
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	22.69	11.35
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	58.80	28.25
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	46.66	26.16
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	34.48	14.99
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	24.11	13.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	30.92	13.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	23.18	10.96
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	26.29	14.04
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	22.06	14.23
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	26.01	12.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	46.37	27.34
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	47.07	28.24
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	40.42	23.68
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	37.67	17.25
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	49.41	22.81
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	35.41	22.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	24.30	12.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	29.89	17.93
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	15.65	9.75
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	20.71	12.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	19.69	19.69
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	23.86	18.15
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	41.30	29.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	28.52	20.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	43.42	24.88
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	46.45	29.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	9.76	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	36.07	23.50
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	41.05	13.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	22.44	13.75
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	27.76	14.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	13.13	8.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	30.61	19.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	23.44	17.51
immature langerhans cells, donor1	11904-125F5	3.87	1.70
immature langerhans cells, donor2	11905-125F6	3.96	1.58
insula, adult, pool1	10039-101F3	27.63	16.56
keratoacanthoma cell line:HKA-1	10791-110H8	19.51	27.31
kidney, adult, pool1	10017-101C8	30.84	11.61
kidney, fetal, pool1	10045-101F9	26.03	15.56
large cell lung carcinoma cell line:IA-LM	10509-107D5	25.42	21.87
large cell lung carcinoma cell line:NCI-H460	10839-111E2	9.68	5.25
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	13.95	8.44
left atrium, adult, donor1	10079-102A7	37.05	21.79
left ventricle, adult, donor1	10078-102A6	24.78	17.70
leiomyoblastoma cell line:G-402	10721-110A1	33.38	14.23
leiomyoma cell line:10964C	10569-108B2	25.51	11.86
leiomyoma cell line:15242A	10570-108B3	23.37	6.52
leiomyoma cell line:15425	10571-108B4	34.24	12.63
leiomyosarcoma cell line:Hs 5.T	10722-110A2	38.10	19.05
lens epithelial cell line:SRA 01/04	10647-109A8	24.05	9.41
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	17.83	12.16
liposarcoma cell line:KMLS-1	10782-110G8	23.59	12.18
liposarcoma cell line:SW 872	10726-110A6	28.51	15.35
liver, adult, pool1	10018-101C9	15.88	8.43
liver, fetal, pool1	10086-102B5	18.81	5.64
locus coeruleus - adult, donor10196	10182-103D2	15.60	6.71
locus coeruleus, adult, donor10252	10165-103B3	18.46	5.35
locus coeruleus, adult, donor10258	10375-105G6	27.93	11.00
locus coeruleus, newborn, donor10223	10362-105F2	10.52	5.89
lung adenocarcinoma cell line:A549	10499-107C4	10.10	6.92
lung adenocarcinoma cell line:PC-14	10408-106B3	14.48	6.20
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	21.62	17.00
lung, adult, pool1	10019-101D1	16.66	8.03
lung, fetal, donor1	10068-101I5	11.99	6.85
lung, right lower lobe, adult, donor1	10075-102A3	30.24	14.66
lymph node, adult, donor1	10077-102A5	19.41	4.26
lymphangiectasia cell line:DS-1	10727-110A7	10.08	6.58
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	27.62	13.43
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	22.09	20.39
mature adipocyte, donor1	12231-129F8	37.74	12.43
mature adipocyte, donor2	12232-129F9	39.22	14.53
mature adipocyte, donor3	12233-129G1	37.22	11.85
mature adipocyte, donor4	12234-129G2	18.69	9.74
maxillary sinus tumor cell line:HSQ-89	10414-106B9	33.12	20.25
medial frontal gyrus - adult, donor10196	10170-103B8	14.66	6.77
medial frontal gyrus, adult, donor10252	10150-102I6	17.66	6.99
medial frontal gyrus, adult, donor10258	10368-105F8	16.52	5.72
medial frontal gyrus, newborn, donor10223	10352-105E1	2.99	2.56
medial temporal gyrus - adult, donor10196	10183-103D3	23.12	6.08
medial temporal gyrus, adult, donor10252	10156-103A3	16.55	8.49
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	19.26	7.71
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	16.51	5.74
medulla oblongata - adult, donor10196	10174-103C3	17.52	8.44
medulla oblongata, adult, donor10252	10155-103A2	21.36	9.44
medulla oblongata, adult, pool1	10038-101F2	19.43	10.94
medulla oblongata, newborn, donor10223	10361-105F1	13.54	5.21
medulloblastoma cell line:D283 Med	10838-111E1	21.92	14.39
medulloblastoma cell line:ONS-76	10759-110E3	30.32	17.97
melanoma cell line:COLO 679	10514-107E1	19.55	12.22
melanoma cell line:G-361	10465-106H6	23.62	13.03
meningioma cell line:HKBMM	10691-109F7	9.05	2.17
merkel cell carcinoma cell line:MKL-1	10843-111E6	22.91	22.03
merkel cell carcinoma cell line:MS-1	10844-111E7	58.07	58.07
mesenchymal precursor cell - adipose, donor1	11747-123G1	28.39	14.58
mesenchymal precursor cell - adipose, donor2	11748-123G2	11.63	6.54
mesenchymal precursor cell - adipose, donor3	11749-123G3	12.42	10.35
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	18.26	12.36
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	20.03	10.01
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	18.05	13.19
mesenchymal precursor cell - cardiac, donor1	11752-123G6	11.16	7.90
mesenchymal precursor cell - cardiac, donor2	11753-123G7	20.70	10.47
mesenchymal precursor cell - cardiac, donor3	11754-123G8	20.56	11.14
mesenchymal precursor cell - cardiac, donor4	11755-123G9	22.82	12.69
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	26.75	10.39
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	14.16	4.94
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	18.68	9.41
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	27.93	15.36
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	19.60	9.60
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	21.93	11.50
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	14.69	6.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	18.24	8.66
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	28.53	14.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	16.29	7.47
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	19.34	9.80
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	22.83	8.84
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	19.46	12.88
mesenchymal stem cell line:Hu5/E18	10568-108B1	45.47	22.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	18.27	9.59
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	18.67	9.72
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	22.77	9.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	21.87	11.09
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	14.83	6.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	17.94	5.75
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	16.50	5.50
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	19.00	12.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	24.52	8.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	19.41	8.48
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	17.55	8.89
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	21.27	9.53
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	15.78	11.08
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	17.19	9.42
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	17.61	10.74
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	16.41	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	18.19	6.50
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	17.46	7.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	22.92	9.06
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	24.53	8.18
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	15.94	10.50
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	20.99	12.59
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	15.90	6.95
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	33.37	9.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	23.13	11.27
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	18.28	13.40
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	34.84	8.87
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	17.25	6.55
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	12.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	6.89
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	11.00	6.52
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	19.07	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	15.92	8.84
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	18.08	11.84
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	25.40	5.35
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	18.92	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	12.84
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	17.21	6.88
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	23.75	10.39
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	14.58	12.34
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	22.90	12.09
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	23.37	8.06
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	26.17	21.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	22.81	15.20
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	17.60	8.50
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	22.59
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	18.12	9.06
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	32.94	13.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	23.04	8.76
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	26.48	5.09
mesodermal tumor cell line:HIRS-BM	10696-109G3	7.74	7.74
mesothelioma cell line:ACC-MESO-1	10493-107B7	24.10	11.81
mesothelioma cell line:ACC-MESO-4	10494-107B8	29.42	14.36
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	17.09
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	8.32	5.24
mesothelioma cell line:Mero-25	10850-111F4	10.44	7.49
mesothelioma cell line:Mero-41	10851-111F5	27.14	10.76
mesothelioma cell line:Mero-48a	10852-111F6	12.84	6.86
mesothelioma cell line:Mero-82	10853-111F7	18.40	16.82
mesothelioma cell line:Mero-83	10854-111F8	18.89	10.55
mesothelioma cell line:Mero-84	10855-111F9	17.19	12.13
mesothelioma cell line:Mero-95	10856-111G1	21.33	11.80
mesothelioma cell line:NCI-H2052	10847-111F1	28.33	19.55
mesothelioma cell line:NCI-H226	10846-111E9	27.69	21.72
mesothelioma cell line:NCI-H2452	10848-111F2	35.02	14.69
mesothelioma cell line:NCI-H28	10845-111E8	10.43	0.76
mesothelioma cell line:No36	10857-111G2	19.57	9.13
mesothelioma cell line:ONE58	10858-111G3	18.70	10.84
migratory langerhans cells, donor1	11901-125F2	5.95	4.03
migratory langerhans cells, donor2	11902-125F3	11.11	5.98
migratory langerhans cells, donor3	11903-125F4	11.67	4.13
mixed mullerian tumor cell line:HTMMT	10689-109F5	31.67	16.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	18.86	18.86
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	17.05	22.11
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	17.70	7.04
myelodysplastic syndrome cell line:SKM-1	10772-110F7	42.50	20.14
myeloma cell line:PCM6	10474-106I6	15.81	21.55
myxofibrosarcoma cell line:MFH-ino	10600-108E6	12.68	9.13
myxofibrosarcoma cell line:NMFH-1	10684-109E9	35.31	25.11
nasal epithelial cells, donor1, tech_rep1	12226-129F3	15.27	10.36
nasal epithelial cells, donor1, tech_rep2	12226-129F3	10.30	8.60
nasal epithelial cells, donor2	12227-129F4	16.01	6.62
neuroblastoma cell line:CHP-134	10508-107D4	12.65	6.44
neuroblastoma cell line:NB-1	10539-107G8	24.13	11.41
neuroblastoma cell line:NBsusSR	10607-108F4	14.13	6.54
neuroblastoma cell line:NH-12	10555-107I6	16.59	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	11.39	5.93
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	31.52	9.19
neuroectodermal tumor cell line:TASK1	10774-110F9	27.98	20.93
neuroepithelioma cell line:SK-N-MC	10728-110A8	29.88	12.08
neurofibroma cell line:Hs 53.T	10729-110A9	27.95	1.60
neutrophil PMN, donor1	12133-128D9	29.75	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	26.04	19.28
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	16.81	7.20
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	24.69	14.11
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	30.74	14.71
nucleus accumbens, adult, pool1	10037-101F1	29.34	18.00
occipital cortex - adult, donor10196	10172-103C1	22.66	10.30
occipital cortex, adult, donor10252	10163-103B1	19.05	7.25
occipital cortex, newborn, donor10223	10355-105E4	14.92	5.82
occipital lobe, adult, donor1	10076-102A4	32.80	12.07
occipital lobe, fetal, donor1	10073-102A1	21.46	3.43
occipital pole, adult, pool1	10036-101E9	25.54	13.64
olfactory region, adult	10195-103E6	12.04	7.26
optic nerve, donor1	10277-104E7	20.01	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	13.67	9.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	21.98	14.43
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	13.04	11.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	14.55	12.01
osteoclastoma cell line:Hs 706.T	10704-109H2	23.81	12.93
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	29.90	11.21
osteosarcoma cell line:HS-Os-1	10558-107I9	26.08	23.54
ovary, adult, pool1	10020-101D2	15.55	2.71
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	27.13	14.12
pancreas, adult, donor1	10049-101G4	24.46	15.05
pancreatic carcinoma cell line:NOR-P1	10698-109G5	32.71	21.52
papillary adenocarcinoma cell line:8505C	10437-106E5	14.99	9.88
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	15.56	11.26
paracentral gyrus, adult, pool1	10035-101E8	25.90	14.92
parietal cortex, adult, donor10258	10373-105G4	15.41	5.14
parietal lobe - adult, donor10196	10171-103B9	15.05	7.52
parietal lobe, adult, donor10252	10157-103A4	11.97	4.85
parietal lobe, adult, pool1	10034-101E7	24.67	12.69
parietal lobe, fetal, donor1	10072-101I9	8.73	5.82
parietal lobe, newborn, donor10223	10356-105E5	10.47	4.11
parotid gland, adult	10199-103F1	21.58	3.70
penis, adult	10200-103F2	27.93	13.96
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	6.69	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	31.91	29.58
pineal gland - adult, donor10196	10179-103C8	20.64	27.74
pineal gland, adult, donor10252	10160-103A7	45.01	42.64
pineal gland, adult, donor10258	10377-105G8	18.19	25.08
pituitary gland - adult, donor10196	10180-103C9	35.41	15.18
pituitary gland, adult, donor10252	10162-103A9	63.06	40.13
pituitary gland, adult, donor10258	10378-105G9	20.43	15.32
placenta, adult, pool1	10021-101D3	25.26	15.05
plasma cell leukemia cell line:ARH-77	10840-111E3	15.63	8.61
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	30.66	14.94
pons, adult, pool1	10033-101E6	19.80	10.59
postcentral gyrus, adult, pool1	10032-101E5	27.63	15.34
promyelocytes/myelocytes PMC, donor1	12132-128D8	18.82	8.37
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	11.02
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	11.74
prostate cancer cell line:DU145	10490-107B4	44.43	21.27
prostate cancer cell line:PC-3	10439-106E7	88.94	62.44
prostate, adult, pool1	10022-101D4	20.31	9.61
putamen, adult, donor10196	10176-103C5	20.77	9.44
putamen, adult, donor10252	10152-102I8	45.10	9.80
putamen, adult, donor10258, tech_rep1	10372-105G3	18.58	8.74
putamen, adult, donor10258, tech_rep2	10372-105G3	35.28	16.67
putamen, newborn, donor10223	10365-105F5	11.24	3.00
rectal cancer cell line:TT1TKB	10469-106I1	13.09	8.44
rectum, fetal, donor1	10067-101I4	29.21	8.35
renal cell carcinoma cell line:OS-RC-2	10411-106B6	34.34	22.47
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	10.36	0.41
retina, adult, pool1	10030-101E3	34.69	24.25
retinoblastoma cell line:Y79	10475-106I7	30.40	23.38
rhabdomyosarcoma cell line:KYM-1	10787-110H4	41.19	20.53
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	46.68	23.06
sacrococcigeal teratoma cell line:HTST	10695-109G2	12.13	2.27
salivary acinar cells, donor1	11771-123I7	12.62	8.09
salivary acinar cells, donor2	11772-123I8	14.73	11.84
salivary acinar cells, donor3	11773-123I9	8.61	11.92
salivary gland, adult, pool1	10093-102C3	15.44	9.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	15.18	12.14
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	17.87	9.40
seminal vesicle, adult	10201-103F3	21.69	7.41
serous adenocarcinoma cell line:JHOS-2	10639-108I9	19.19	14.33
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	23.65	6.54
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	50.18	10.04
serous cystadenocarcinoma cell line:HTOA	10693-109F9	33.58	16.92
signet ring carcinoma cell line:Kato III	10436-106E4	26.53	17.68
signet ring carcinoma cell line:NUGC-4	10483-107A6	21.29	16.77
skeletal muscle - soleus muscle, donor1	10282-104F3	12.77	12.77
skeletal muscle, adult, pool1	10023-101D5	33.34	27.95
skeletal muscle, fetal, donor1	10066-101I3	26.13	6.03
skin, adult, donor1	10074-102A2	33.93	20.36
skin, fetal, donor1	10065-101I2	24.62	15.15
small cell cervical cancer cell line:HCSC-1	10800-110I8	55.36	30.35
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	25.53	15.76
small cell lung carcinoma cell line:DMS 144	10841-111E4	60.52	24.48
small cell lung carcinoma cell line:LK-2	10541-107H1	17.31	14.67
small cell lung carcinoma cell line:NCI-H82	10842-111E5	19.46	6.59
small cell lung carcinoma cell line:WA-hT	10562-108A4	46.20	31.82
small intestine, adult, pool1	10024-101D6	35.95	25.08
small intestine, fetal, donor1	10064-101I1	23.59	18.43
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	32.83	16.41
smooth muscle, adult, pool1	10048-101G3	20.42	12.66
somatostatinoma cell line:QGP-1	10781-110G7	26.53	15.01
spinal cord - adult, donor10196	10181-103D1	16.06	9.41
spinal cord, adult, donor10252	10159-103A6	20.90	8.67
spinal cord, adult, donor10258	10369-105F9	3.46	1.38
spinal cord, fetal, donor1	10056-101H2	25.61	10.98
spinal cord, newborn, donor10223	10359-105E8	11.02	5.51
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	29.42	15.68
spleen, adult, pool1	10025-101D7	15.20	8.59
spleen, fetal, pool1	10044-101F8	15.33	9.77
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	14.08	7.56
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	7.97	8.35
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	35.99	33.20
squamous cell carcinoma cell line:T3M-5	10616-108G4	9.38	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	33.32	31.97
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	13.98	8.05
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	19.88	11.85
stomach, fetal, donor1	10062-101H8	29.90	6.41
submaxillary gland, adult	10202-103F4	26.77	15.38
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	18.07	9.55
substantia nigra, adult, donor10258	10371-105G2	11.38	5.17
substantia nigra, newborn, donor10223	10358-105E7	16.96	7.77
synovial sarcoma cell line:HS-SY-II	10441-106E9	28.89	14.90
temporal lobe, adult, pool1	10031-101E4	24.41	14.50
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	16.38	3.56
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	11.43	1.76
tenocyte, donor1	11763-123H8	36.66	15.36
tenocyte, donor2	11765-123I1	23.65	9.54
tenocyte, donor3	11768-123I4	30.39	14.83
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	77.84	58.30
teratocarcinoma cell line:NCR-G1	10798-110I6	28.36	16.19
teratocarcinoma cell line:PA-1	10807-111A6	47.11	31.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	28.31	27.29
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	21.93	19.29
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	15.92	16.36
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	21.17	9.12
testis, adult, pool1	10026-101D8	20.62	12.24
testis, adult, pool2	10096-102C6	19.85	13.08
thalamus - adult, donor10196	10168-103B6	13.25	9.94
thalamus, adult, donor10252	10154-103A1	16.41	6.88
thalamus, adult, donor10258, tech_rep1	10370-105G1	18.48	12.32
thalamus, adult, donor10258, tech_rep2	10370-105G1	22.56	8.89
thalamus, newborn, donor10223	10366-105F6	11.51	6.90
throat, adult	10209-103G2	23.97	21.47
throat, fetal, donor1	10061-101H7	25.90	13.71
thymic carcinoma cell line:Ty-82	10803-111A2	29.21	14.31
thymus, adult, pool1	10027-101D9	20.78	9.64
thymus, fetal, pool1	10043-101F7	16.62	7.90
thyroid carcinoma cell line:KHM-5M	10776-110G2	29.92	17.95
thyroid carcinoma cell line:TCO-1	10783-110G9	35.34	18.72
thyroid, adult, pool1	10028-101E1	29.67	14.56
thyroid, fetal, donor1	10060-101H6	29.53	9.49
tongue epidermis (fungiform papillae), donor1	10288-104F9	6.16	3.08
tongue, adult	10203-103F5	29.07	27.68
tongue, fetal, donor1	10059-101H5	33.89	40.99
tonsil, adult, pool1	10047-101G2	27.45	17.83
trachea, adult, pool1	10029-101E2	23.15	17.34
trachea, fetal, donor1	10058-101H4	20.77	14.62
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	27.63	14.53
transitional-cell carcinoma cell line:5637	10418-106C4	28.37	22.80
transitional-cell carcinoma cell line:JMSU1	10492-107B6	31.81	14.42
tridermal teratoma cell line:HGRT	10694-109G1	17.12	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	20.40	13.04
umbilical cord, fetal, donor1	10057-101H3	39.64	14.61
uterus, adult, pool1	10100-102D1	18.77	8.02
uterus, fetal, donor1	10055-101H1	29.18	14.33
vagina, adult	10204-103F6	15.51	10.34
vein, adult	10191-103E2	14.03	8.33
xeroderma pigentosum b cell line:XPL 17	10563-108A5	6.68	2.40